PR Newswire
CAMBRIDGE, Mass., Sept. 26, 2018
CAMBRIDGE, Mass., Sept. 26, 2018 /PRNewswire/ -- Infinity
Pharmaceuticals, Inc. (NASDAQ: INFI) will be presenting at Cantor Fitzgerald's Global Healthcare Conference on Wednesday, October 3, 2018, at 5:10 p.m. ET at the Intercontinental New York
Barclay Hotel in New York, NY. A live webcast of the presentation will be available on the
Investors/Media section of Infinity's website at www.infi.com, and will be available for 30 days following the event.
About Infinity
Infinity is an innovative biopharmaceutical company dedicated to advancing novel cancer treatments. Infinity is
advancing IPI-549, a potentially transformative immuno-oncology approach that aims to reprogram tumor-associated macrophages by
selectively inhibiting PI3K-gamma. A Phase 1/1b study in approximately 200 patients with advanced
solid tumors is ongoing. For more information on Infinity, please refer to Infinity's website at www.infi.com.
Contact:
Stephanie Ascher, Stern Investor Relations, Inc.
212-362-1200 or Stephanie@sternir.com
View original content:http://www.prnewswire.com/news-releases/infinity-to-present-at-cantor-fitzgerald-global-healthcare-conference-300719031.html
SOURCE Infinity Pharmaceuticals, Inc.